Mechanism & research context
Pre-filled cartridge of tirzepatide in sterile solution, supplied without an injection pen. Intended for laboratory dosing-format research. Supplied as lyophilized powder at ≥98% HPLC purity.
Selected studies
"Tirzepatide achieved up to 20.9% body-weight reduction at 72 weeks in adults with obesity."
New England Journal of Medicine — SURMOUNT-1 trialView study
Use disclaimerFor Research Use Only. Not for Human Consumption. Not a drug, food, or cosmetic.
Article reflects published preclinical and in-vitro literature..